Nuvectis Pharma, Inc.

NasdaqCM:NVCT Stock Report

Market Cap: US$121.5m

Nuvectis Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:NVCT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 May 24BuyUS$13,076Ron BentsurIndividual1,940US$6.74
10 May 24BuyUS$7,034Shay ShemeshIndividual1,113US$6.32
10 May 24BuyUS$3,145Enrique PoradosuIndividual500US$6.29
10 May 24BuyUS$12,800Ron BentsurIndividual2,000US$6.40
18 Mar 24BuyUS$51,450Ron BentsurIndividual5,000US$10.29
10 Oct 23BuyUS$7,091Ron BentsurIndividual640US$11.08
09 Oct 23BuyUS$12,105Ron BentsurIndividual1,080US$11.27
05 Oct 23BuyUS$35,455Ron BentsurIndividual3,220US$11.09
16 Aug 23BuyUS$5,112Ron BentsurIndividual350US$15.15
11 Aug 23BuyUS$4,418Ron BentsurIndividual300US$14.83
31 Jul 23BuyUS$11,937Charles Mosseri-MarlioIndividual860US$13.88
28 Jul 23BuyUS$35,943Charles Mosseri-MarlioIndividual2,584US$13.91

Insider Trading Volume

Insider Buying: NVCT insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NVCT?
Owner TypeNumber of SharesOwnership Percentage
Institutions2,508,12913.7%
General Public3,839,97520.9%
Individual Insiders12,007,95665.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.7%.


Top Shareholders

Top 25 shareholders own 78.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.7%
Ron Bentsur
3,066,424US$20.3m1.45%no data
14.1%
Charles Mosseri-Marlio
2,595,000US$17.2m0%no data
13%
Charles Marlio
2,380,176US$15.8m0%no data
7.67%
Enrique Poradosu
1,407,652US$9.3m4.36%no data
7.61%
Shay Shemesh
1,396,401US$9.2m6.03%no data
5%
Pontifax Venture Capital
917,400US$6.1m0%2.24%
4.95%
Thomas Peters
908,475US$6.0m0%no data
2.03%
BlackRock, Inc.
372,721US$2.5m-3.91%no data
1.63%
The Vanguard Group, Inc.
298,800US$2.0m1.53%no data
0.92%
Baldwin Brothers, LLC
168,630US$1.1m9.41%0.09%
0.73%
Geode Capital Management, LLC
134,528US$890.6k2.18%no data
0.7%
State Street Global Advisors, Inc.
129,379US$856.5k9.38%no data
0.56%
Kenneth Hoberman
103,140US$682.8k41%no data
0.46%
Matthew Kaplan
83,760US$554.5k55.8%no data
0.34%
Northern Trust Global Investments
62,097US$411.1k0.85%no data
0.34%
Renaissance Technologies LLC
61,700US$408.5k19.1%no data
0.32%
James Oliviero
57,828US$382.8k108%no data
0.27%
Marshall Wace LLP
50,068US$331.5k102%no data
0.22%
Morgan Stanley, Investment Banking and Brokerage Investments
41,142US$272.4k80.1%no data
0.22%
Millennium Management LLC
39,501US$261.5k16.1%no data
0.21%
GSA Capital Partners LLP
39,282US$260.0k43.8%0.02%
0.19%
J.M. Forbes & Co. LLP
34,000US$225.1k0%0.02%
0.11%
Charles Schwab Investment Management, Inc.
19,920US$131.9k0%no data
0.1%
Edmond de Rothschild Asset Management (France)
19,170US$126.9k0%no data
0.097%
BNY Asset Management
17,755US$117.5k-7.28%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.